Dokumendiregister | Terviseamet |
Viit | 11.1-2/24/1571-2 |
Registreeritud | 08.02.2024 |
Sünkroonitud | 27.03.2024 |
Liik | Väljaminev dokument |
Funktsioon | 11.1 Turustamise järgne järelevalve (post-marketing surveillance) |
Sari | 11.1-2 Kirjavahetus Eesti turule lastavatest/kasutusele võetavatest/levitatavatest seadmetest MSA kaudu teavitamiseks |
Toimik | 11.1-2/2024 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | Fitbit LLC |
Saabumis/saatmisviis | Fitbit LLC |
Vastutaja | Karl Kalev Türk (TA, Peadirektori asetäitja (1) vastutusvaldkond, Meditsiiniseadmete osakond) |
Originaal | Ava uues aknas |
From: Meditsiiniseadmed (Medical Devices)
Sent: Thu, 08 Feb 2024 12:39:38 +0000
To: Alina Mihai <[email protected]>
Cc: Shruti Rajagopalan <[email protected]>
Subject: Vs: Medical Device Software - Notification
Dear Alina,
Thank you for your inquiry.
I would like to provide you with the link to the current version of the Medical Device Act. The one mentioned in your letter is actually an older version that was in force until 31.01.2022.
Compared to the older version, the distribution notification requirement has also changed. It can now be found in § 26 (4) and is worded as follows:
Every undertaking who distributes on the market of Estonia a system or procedure pack of medical devices according to Article 22 of Regulation (EU) 2017/745 of the European Parliament and of the Council or a class IIa, IIb or III medical device classified according to Regulation (EU) 2017/745 of the European Parliament and of the Council or Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices or Council Directive 93/42/EEC concerning medical devices or class B, C or D in vitro diagnostic medical devices classified according to Annex VIII of Regulation (EU) 2017/746 of the European Parliament and of the Council, shall notify the Health Board thereof within 10 days after distribution of the relevant medical device for the first time.
The notification process does not require an importer or distributor established in Estonia to notify us. It is quite common for the manufacturer, in the case of direct distribution, to handle the notification itself.
The distribution notification can be submitted through the Estonian Medical Device Database (EMDDB, https://msa.sm.ee/).
In the case of a non-Estonian user unable to use the national secure authentication method for e-services, we can manually create an account. This allows access to the database using a username and password. To create an account, we need the full name and email of a contact person. The account itself is personal (not for the company). The person then adds the company to the database and links themselves to it.
Additionally, there is a short guide for using the Estonian Medical Device Database available on the database homepage under „Forms“. It provides a step-by-step guide on how to successfully submit notifications in the database. It may be worth taking a look to understand the process overall.
If you have any further questions, feel free to ask.
Best regards,
Karl Kalev Türk
Chief Specialist
Department of Medical Devices
Phone +372 5648 5663
[email protected] | [email protected]
Republic of Estonia Terviseamet | Health Board +372 794 3500 [email protected] Paldiski mnt 81, 10614 Tallinn Estonia |
This e-mail is confidential and meant for use by the person named in the letterhead. Any use in any way or copying of it by a person not marked as the addressee thereof is prohibited. If you have got this e-mail by mistake, please notify of it the sender without delay and delete the received e-mail together with all its attachments.
Saatja: Alina Mihai <[email protected]>
Saatmisaeg: neljapäev, 8. veebruar 2024 12:36
Adressaat: Meditsiiniseadmed (Medical Devices) <[email protected]>
Koopia: Shruti Rajagopalan <[email protected]>
Teema: Medical Device Software - Notification
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. |
Dear Sir/ Madam,
I'm writing on behalf of Regulatory Dep. of Fitbit LLC, regarding the registration of a Medical Device Software (MDSW), class IIa under Regulation (EU) 2017/745. The medical device is now bearing the CE mark issued by TUV SUD.
According to the Estonian Medical Devices Act, a notification should be submitted to the Health Board when a medical device is distributed in Estonia for the first time. The notification process requires an importer or distributor established in Estonia.
In this scenario, the software is downloaded directly from the manufacturer's website and the Play Store. Consequently, the transaction is free of charge and does not necessitate the involvement of an importer or distributor in the supply chain.
Given that the medical device is distributed directly by a US manufacturer, could you kindly provide guidance on the requirements pertaining to registrations?
Thank you for your time and support!
Kind regards,
Alina Mihai
Alina A. Mihai | | Sr. Regulatory Affairs Specialist | | DSPA/Fitbit | | +40-754-451-469 |
Nimi | K.p. | Δ | Viit | Tüüp | Org | Osapooled |
---|---|---|---|---|---|---|
Kiri | 08.02.2024 | 48 | 11.1-2/24/1571-1 | Sissetulev dokument | ta | Fitbit LLC |
Vastuskiri | 08.02.2024 | 48 | 11.1-2/24/1571-5 🔒 | Sissetulev dokument | ta | Fitbit LLC |
Vastuskiri | 08.02.2024 | 48 | 11.1-2/24/1571-4 🔒 | Väljaminev dokument | ta | Fitbit LLC |
Vastuskiri | 08.02.2024 | 48 | 11.1-2/24/1571-3 🔒 | Sissetulev dokument | ta | Fitbit LLC |